Increased DNA methylation variability in type 1 diabetes across three immune effector cell types
Dirk S. Paul(AstraZeneca (United Kingdom)), Richard David Leslie(Queen Mary University of London)
Cited by 194
Related Papers
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
|Nature Immunology|2023|724
Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome
|Nature Genetics|2012|426
Identification of Type 1 Diabetes–Associated DNA Methylation Variable Positions That Precede Disease Diagnosis
|PLoS Genetics|2011|347
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
|Nature Biotechnology|2016|347